Schedule 13D ownership disclosure

APPLIED THERAPEUTICS INC

Security class unavailable · CUSIP: 03828A101

Event date: 2024-03-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
8,646,891
Percent of class
8.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001341004-24-000056
Form type
SC 13D/A
Filer
Applied Therapeutics, Inc.
CIK
CIK 1697532
Filed
Mar 05, 2024
Reporting period
Mar 01, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub